CD5 on dendritic cells regulates CD4+ and CD8+ T cell activation and induction of immune responses

Hui Li1, Erica Burgueño-Bucio2, Shin Xu1

  • 1Department of Dermatology, University of Alabama at Birmingham. Birmingham, Alabama, United States of America.

Plos One
|September 7, 2019
PubMed

Insights

The immune system uses CD5 on dendritic cells (DCs) to regulate T cell responses. Removing CD5 from DCs boosts their ability to activate T cells and fight tumors.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • CD5 is a known regulator of T cell signaling and tolerance.
  • Expression of CD5 on human dendritic cells (DCs) is recent data, but its function is poorly understood.

Purpose of the Study:

  • To investigate the functional role of CD5 on DCs in modulating immune responses.
  • To understand how CD5 expression on DCs impacts T cell activation and cytokine production.

Main Methods:

  • CD5 expression was analyzed on murine dendritic cell (DC) subtypes.
  • DC subpopulations in CD5 knockout (CD5-/-) and wild-type (CD5+/+) mice were compared.
  • Cytokine production (IL-12, IL-2, IFN-gamma) by DCs and T cells was measured.
  • In vitro and in vivo T cell activation assays were performed.
  • Anti-tumor immunity and contact hypersensitivity responses were assessed in mice.

Main Results:

  • CD5 is expressed on CD11c+ DCs in various murine tissues.
  • CD5-deficient DCs produced higher levels of IL-12 in response to LPS compared to wild-type DCs.
  • CD5-/- DCs enhanced CD4+ and CD8+ T cell activation, leading to increased IL-2 and IFN-gamma production.
  • CD5-/- DCs were more potent in inducing anti-tumor immunity and contact hypersensitivity.
  • Restoring CD5 expression on CD5-/- DCs reduced IL-12 production and T cell stimulation.

Conclusions:

  • CD5 expression on DCs inhibits inflammatory cytokine production.
  • CD5 plays a regulatory role in DC activity, impacting T cell stimulation and immune responses.
  • This study uncovers a novel regulatory function for CD5 on DCs, offering new insights into DC biology.

Related Concept Videos

Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells02:40

Effect of an Immunomodulatory Pharmacological Agent on the Interaction Between Dendritic Cells and CD4+ T Cells

This video demonstrates a method of converting dendritic cells (DCs) to tolerogenic DCs (TolDCs) using an immunomodulatory pharmacological agent. This conversion is confirmed by evaluating the TolDC function through their immunosuppressive effect on CD4+ T...
583
Cell Cycle Analysis: Assessing CD4 and CD8 T Cell Proliferation After Stimulation Using CFSE Staining and Flow Cytometry10:57

Cell Cycle Analysis: Assessing CD4 and CD8 T Cell Proliferation After Stimulation Using CFSE Staining and Flow Cytometry

Source: Perchet Thibaut1,2,3, Meunier Sylvain1,2,3, Sophie Novault4, Rachel Golub1,2,3
1 Unit for Lymphpoiesis, Department of Immunology, Pasteur Institute, Paris, France
2 INSERM U1223, Paris, France
3 Université Paris Diderot, Sorbonne Paris Cité, Cellule Pasteur, Paris, France
4 Flow Cytometry Platfrom, Cytometry and Biomarkers UtechS, Center for Translational Science, Pasteur Institute, Paris, France
The cell cycle is a universal process of life. During the cell cycle, a cell...
25.8K
Flow Cytometry-Based Analysis of Dendritic Cell Activation Using Immune Complexes03:35

Flow Cytometry-Based Analysis of Dendritic Cell Activation Using Immune Complexes

This video demonstrates a protocol for assessing the activation of dendritic cells using immunoglobulin G (IgG)-coated tumor cells. Dendritic cells internalize the IgG-coated tumor cells, process the tumor antigens, and present them on the surface through MHC-II molecules, along with the co-expression of the costimulatory molecule CD86. These dendritic cells then undergo MHC-II and CD86-targeted immunostaining and flow cytometry analysis to identify their activation...
636
An In Vivo Mouse Model to Measure Naïve CD4 T Cell Activation, Proliferation and Th1 Differentiation Induced by Bone Marrow-derived Dendritic Cells08:39

An In Vivo Mouse Model to Measure Naïve CD4 T Cell Activation, Proliferation and Th1 Differentiation Induced by Bone Marrow-derived Dendritic Cells

Here, we present a protocol for the in vivo determination of naïve CD4 T cell (T cell) activation, proliferation, and Th1 differentiation induced by GM-CSF bone marrow (BM)-derived dendritic cells (DCs). In addition, this protocol describes BM and T-cell isolation, DC generation, and DC and T-cell adoptive...
20.4K
A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells16:04

A Tetracycline-regulated Cell Line Produces High-titer Lentiviral Vectors that Specifically Target Dendritic Cells

Here, we use retroviral transduction and concatemeric transfection to create a cell line that can express the components of a lentiviral vector (LV) in the absence of tetracycline. This LV encodes GFP and is pseudotyped with a glycoprotein, SVGmu, which is specific for a receptor on dendritic...
15.0K
Isolation and Characterization of the Immune Cells from Micro-dissected Mouse Choroid Plexuses09:55

Isolation and Characterization of the Immune Cells from Micro-dissected Mouse Choroid Plexuses

This study uses flow cytometry and two different gating strategies on isolated perfused mice brain choroid plexuses; this protocol identifies the main immune cell subsets that populate this brain...
8.2K